Dr Carolyn Luscombe, Head of Research and Development, has...

Dr Carolyn Luscombe, Head of Research and Development, has received an award at the HIV DART and Emerging Viruses 2018 in Miami, Florida for the presentation entitled“BIT225-009: Significant Immunological Outcomes after 12 weeks of BIT225 and Antiretroviral Therapy in an HIV-1 Phase 2 Clinical Trial”.

The award is an acknowledgement of the importance of the outcomes from the Phase 2 trial data presented, as well as the robustness of the science underlying the Company’s programs. 

Thank you for your interest in Biotron.

Regards Michelle

Dr Michelle Miller | CEO & Managing Director | Biotron Limited